Relevant Links
Professor Gilbert’s chief research interest is the development of vaccines that work by inducing strong and protective T cell responses. Following the discovery that heterologous prime-boost immunisation, in which the same antigen is delivered in first one vector and then another, is highly immunogenic in pre-clinical studies, she designed antigen inserts for, and produced DNA, MVA and fowlpox vaccines which were then manufactured for clinical trials in both the malaria and tuberculosis vaccine clinical programmes.
| # | Episode Title | Description | People | Date | |
|---|---|---|---|---|---|
| 4 | Creative Commons | The Pandemic People: Dame Sarah Gilbert | Dame Sarah Gilbert, Professor of Vaccinology at Oxford University, talks about her life in science and her work with a talented and dedicated team at Oxford in developing and testing the Oxford–AstraZeneca vaccine for COVID-19. | Sarah Gilbert | 30 Jun 2023 |
| 3 | Coronavirus and ‘Disease X’ | Professor Peter Millican interviews the Oxford scientists working at the forefront of research into Disease X | Peter Millican, Sarah Gilbert, Peter Horby, Jimmy Whitworth | 14 Jan 2021 | |
| 2 | Creative Commons | Viral vectored vaccine development | Professor Sarah Gilbert talks about her work on viral vectored vaccines. | Sarah Gilbert | 14 Nov 2012 |
| 1 | Creative Commons | Viral vectored vaccine development | Professor Sarah Gilbert talks about her work on viral vectored vaccines. | Sarah Gilbert | 14 Nov 2012 |